US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Direxion Daily S&P Biotech Bull 3x Shares

306.05

-11.1500-3.52%

Volume:81.84K

Turnover:24.79M

Market Cap:650.20M

PE:- -

High:312.79

Open:312.10

Low:297.54

Close:317.20

52wk High:341.93

52wk Low:66.60

Shares:2.12M

Float Shares:2.12M

Volume Ratio:12.61

T/O Rate:3.85%

Dividend:1.02

Dividend Rate:0.33%

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Health Care up on Growth Hopes - Health Care Roundup

American Healthcare REIT completes stock offering for expansion

Outlook Therapeutics Ends ATM Prospectus Amid Ongoing Risks

Spectral AI Advances Commercialization Following DeepView FDA Clearance

U.S. Healthcare Payer Stocks Linked To Medicare Spending Pressure

Simply Wall St.

Press Release: AEON Biopharma Reports Second Quarter 2026 Financial Results and Provides Corporate Update

Sector Update: Healthcare Stocks Advance Late Afternoon

MT Newswires Live

NeuroScientific locks in key US FDA meeting

The West Australian

HC Wainwright Starts Theriva (TOVX) at Buy on Undervalued Oncolytic Virus Platform and Advancing VCN-01 Pancreatic Cancer Program

Acadia Healthcare (ACHC) Securities Lawsuit Moves Forward After Court Denies Dismissal Bid

Analysts Offer Insights on Healthcare Companies: NextCure (NXTC) and CalciMedica (CALC)

Analysts Offer Insights on Healthcare Companies: BioNano Genomics (BNGO), Liquidia Technologies (LQDA) and PolyPid (PYPD)

Freenome Says It Has Obtained FDA Breakthrough Device Designation for Lung Cancer Screening Test

MT Newswires Live

FDA Grants Breakthrough Device Designation to Freenome’s Blood-Based SimpleScreen™ Lung Cancer Screening Test

Analysts Offer Insights on Healthcare Companies: Genmab (GMAB), Definitive Healthcare Corp (DH) and Atai Beckley N.V. (ATAI)

Analysts’ Opinions Are Mixed on These Healthcare Stocks: AIM ImmunoTech (AIM) and Schrodinger (SDGR)

Analysts Offer Insights on Healthcare Companies: 908 Devices (MASS), Pediatrix Medical Group (MD) and BridgeBio Oncology Therapeutics (BBOT)

Autonomix Medical Completes Good Laboratory Practice (GLP) Preclinical Study, Marking Key Step Toward FDA Submission

Analysts Offer Insights on Healthcare Companies: Travere Therapeutics (TVTX), Maze Therapeutics, Inc. (MAZE) and Immunome (IMNM)

TransMedics Buy Rating Reaffirmed as Analyst Maintains $95 Price Target on Robust Multi-Year Growth Outlook

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.etasphere.com/stock/LABU/news?page=16"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"LABU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"LABU\",,,,,undefined,":{"symbol":"LABU","market":"US","secType":"STK","nameCN":"Direxion Daily S&P Biotech Bull 3x Shares","latestPrice":306.05,"timestamp":1787578476024,"preClose":317.2,"halted":0,"volume":81837,"delay":0,"changeRate":-0.035151324085750245,"floatShares":2124486,"shares":2124486,"eps":0,"marketStatus":"Trading","change":-11.15,"latestTime":"08-24 09:34:36 EDT","open":312.1,"high":312.79,"low":297.535,"amount":24791508.46305,"amplitude":0.048093,"askPrice":306.78,"askSize":1,"bidPrice":302.41,"bidSize":300,"shortable":3,"etf":3,"ttmEps":0,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1787601600000},"marketStatusCode":2,"adr":0,"adrRate":0,"exchange":"ARCA","adjPreClose":317.2,"sharesOutstanding":3074486,"nav":316.946,"aum":673347221.03,"dividendRate":0.003316,"bidAskSpread":0.002803,"preHourTrading":{"tag":"盘前","latestPrice":314.59,"preClose":317.2,"latestTime":"09:25 EDT","volume":1055,"amount":335012.8868,"timestamp":1787577900633,"change":-2.61,"changeRate":-0.008228,"amplitude":0.020255},"postHourTrading":{"tag":"盘后","latestPrice":317.87,"preClose":317.2,"latestTime":"19:58 EDT","volume":6645,"amount":2111082.7734,"timestamp":1787356729854,"change":0.67,"changeRate":0.002112,"amplitude":0.006526},"volumeRatio":12.607003,"impliedVol":0.9759,"impliedVolPercentile":0.753},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"LABU\",,,,,undefined,":{"symbol":"LABU","floatShares":2124486,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":12.607003,"shares":2124486,"dividePrice":1.015,"high":312.79,"amplitude":0.048093,"preClose":317.2,"low":297.535,"week52Low":66.6,"pbRate":"--","week52High":341.93,"institutionHeld":0,"latestPrice":306.05,"committee":0.993355,"eps":0,"divideRate":0.003316,"volume":81837,"delay":0,"ttmEps":0,"open":312.1,"prevYearClose":159.39,"prevWeekClose":317.2,"prevMonthClose":227.4,"prevQuarterClose":292.1,"fiveDayClose":287.3,"twentyDayClose":246.27,"sixtyDayClose":191.66},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/LABU\",params:#limit:5,,,undefined,":[{"date":"2025-09-23","symbol":"LABU","amount":0.10273,"announcedDate":"2025-09-22","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-09-23","defaultRemindTime":1758634200000,"name":"三倍做多标普生物-Direxion","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-09-30","payableDate":"2025-09-23","currency":"USD","dateTimestamp":1758600000000,"payDate":"2025-09-30"},{"date":"2025-06-24","symbol":"LABU","amount":0.21897,"announcedDate":"2025-06-23","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-06-24","defaultRemindTime":1750771800000,"name":"三倍做多标普生物-Direxion","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-07-01","payableDate":"2025-06-24","currency":"USD","dateTimestamp":1750737600000,"payDate":"2025-07-01"},{"date":"2025-03-25","symbol":"LABU","amount":0.10714,"announcedDate":"2025-03-24","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-03-25","defaultRemindTime":1742909400000,"name":"三倍做多标普生物-Direxion","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-04-01","payableDate":"2025-03-25","currency":"USD","dateTimestamp":1742875200000,"payDate":"2025-04-01"},{"date":"2024-06-25","symbol":"LABU","amount":0.15021,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-06-25","defaultRemindTime":1719322200000,"name":"三倍做多标普生物-Direxion","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-07-02","payableDate":"2024-06-25","currency":"USD","dateTimestamp":1719288000000,"payDate":"2024-07-02"},{"date":"2024-03-19","symbol":"LABU","amount":0.16064,"announcedDate":"2024-03-18","type":"dividend","market":"US","newRecordDate":"2024-03-20","defaultRemindTime":1710855000000,"name":"三倍做多标普生物-Direxion","recordDate":"2024-03-26","payableDate":"2024-03-20","currency":"USD","dateTimestamp":1710820800000,"payDate":"2024-03-26"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"LABU\",market:\"US\",,,undefined,":[{"executeDate":"2018-06-19","recordDate":"2018-06-20","paymentDate":"2018-06-26","value":0.01932,"currency":"USD"},{"executeDate":"2018-09-25","recordDate":"2018-09-26","paymentDate":"2018-10-02","value":0.0954,"currency":"USD"},{"executeDate":"2018-12-27","recordDate":"2018-12-28","paymentDate":"2019-01-04","value":0.09621,"currency":"USD"},{"executeDate":"2019-03-19","recordDate":"2019-03-20","paymentDate":"2019-03-26","value":0.10973,"currency":"USD"},{"executeDate":"2019-06-25","recordDate":"2019-06-26","paymentDate":"2019-07-02","value":0.03745,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"LABU\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"LABU\",pageSize:20,pageCount:16,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2659418347","title":"Health Care up on Growth Hopes - Health Care Roundup","url":"https://stock-news.laohu8.com/highlight/detail?id=2659418347","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659418347?lang=en_us&edition=fundamental","pubTime":"2026-08-13 05:21","pubTimestamp":1786569660,"startTime":"0","endTime":"0","summary":"Health-care companies rose amid optimism about the growth outlook in the sector.Eli Lilly shares rose after it sued several U.S. entities, including a California spa and online sellers of experimental peptides, alleging they were selling unlicensed versions of one of its obesity drugs.Shares of Canadian drug maker Apotex Health fell after it swung to a quarterly loss on lower revenue. The company said Canadian launches of generic Ozempic and Wegovy obesity drugs helped to offset an expiring cancer-drug license.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","BK4585","XLV","LABU","XBI","BK4581"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659183318","title":"American Healthcare REIT completes stock offering for expansion","url":"https://stock-news.laohu8.com/highlight/detail?id=2659183318","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659183318?lang=en_us&edition=fundamental","pubTime":"2026-08-13 04:54","pubTimestamp":1786568067,"startTime":"0","endTime":"0","summary":"American Healthcare REIT, Inc. ( ($AHR) ) has provided an announcement. On August 12, 2026, American Healthcare REIT closed a public offering of 13...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/american-healthcare-reit-completes-stock-offering-for-expansion?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/american-healthcare-reit-completes-stock-offering-for-expansion?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["XBI","RNTY","PSCF","RJMG","BK4225","REIX","BK4581","BK4585","AHR","BK4588","IVRA","MDIV","YLDW","LABU","XLV","IQRA","REIT","DFRA","BPRE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659926188","title":"Outlook Therapeutics Ends ATM Prospectus Amid Ongoing Risks","url":"https://stock-news.laohu8.com/highlight/detail?id=2659926188","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659926188?lang=en_us&edition=fundamental","pubTime":"2026-08-13 04:37","pubTimestamp":1786567029,"startTime":"0","endTime":"0","summary":"The latest update is out from Outlook Therapeutics ( ($OTLK) ). On July 24, 2026, Outlook Therapeutics announced U.S. FDA approval of LYTENAVA (bev...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/outlook-therapeutics-ends-atm-prospectus-amid-ongoing-risks?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/outlook-therapeutics-ends-atm-prospectus-amid-ongoing-risks?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IEIH","LENZ","BK4007","MRNX","FRTY","TBXU","MRNY","BK4139","LABU","MEDI","GNMX","GDOC","IDNA","BK4588","PINK","IYH","IBB","SYNB","XLVX","NVIB","PSCH","BK4585","BK4539","LFSC","BMED","RSPH","BBP","TECB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659188620","title":"Spectral AI Advances Commercialization Following DeepView FDA Clearance","url":"https://stock-news.laohu8.com/highlight/detail?id=2659188620","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659188620?lang=en_us&edition=fundamental","pubTime":"2026-08-13 04:35","pubTimestamp":1786566957,"startTime":"0","endTime":"0","summary":"Spectral AI ( ($MDAI) ) has issued an announcement. In the second quarter ended June 30, 2026, Spectral AI reported a strong operational transition...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/spectral-ai-advances-commercialization-following-deepview-fda-clearance?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/spectral-ai-advances-commercialization-following-deepview-fda-clearance?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4588","QTOC","VTHR","ARTY","CHAT","AIPO","LABU","BK4585","AGIX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659818301","title":"U.S. Healthcare Payer Stocks Linked To Medicare Spending Pressure","url":"https://stock-news.laohu8.com/highlight/detail?id=2659818301","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659818301?lang=en_us&edition=fundamental","pubTime":"2026-08-13 04:34","pubTimestamp":1786566849,"startTime":"0","endTime":"0","summary":"With the U.S. deficit swelling, Medicare spending in sharper focus and a $39.9b debt pile driving interest costs higher, investors are seeing how government budgets can ripple through markets in real time. That stress can unsettle broad indices yet create pockets of potential in Medicare exposed insurers. In this context, this article walks through 3 U.S. healthcare payer stocks tied to these trends and explains why they might matter for your watchlist.\nThe stocks covered below are just a...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/6033000-choice1-main-header/1585186824821","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6033000-choice1-main-header/1585186824821"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/healthcare/nyse-ardt/ardent-health/news/us-healthcare-payer-stocks-linked-to-medicare-spending-press","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/healthcare/nyse-ardt/ardent-health/news/us-healthcare-payer-stocks-linked-to-medicare-spending-press","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4196","XLV","AIPO","LABU","BK4588","BK4185","BK4581","XBI","BK4082","BK4585","INNV","LNGR","LU0029874061.USD","ARDT","TCMD","BK4137","HCSG","LU0128526141.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659990095","title":"Press Release: AEON Biopharma Reports Second Quarter 2026 Financial Results and Provides Corporate Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2659990095","media":"Dow Jones","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659990095?lang=en_us&edition=fundamental","pubTime":"2026-08-13 04:15","pubTimestamp":1786565700,"startTime":"0","endTime":"0","summary":"-- AEON held a successful Biosimilar Biological Product Development.  Type 2a meeting with the U.S. Food and Drug Administration.  during the first quarter of 2026. During the meeting, the. strategy under the 351 biosimilar pathway and provided feedback. ABP-450. Collectively, the FDA's feedback provided AEON with. well-defined direction and a framework for the remaining. analytical components of its biosimilar development program. The. associated with characterizing the 900 kDa botulinum neurotoxin. complex due to its large size and exceptional potency, while. analytical assessment plan. The Company looks forward to feedback. from its planned BPD Type 2b interaction with the FDA in the. second half of 2026, which is expected to help inform the next. phase of development for ABP-450, including clinical pharmacology. -- Strengthened Balance Sheet through a $15.3 Million Financing with","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AEON","BBP","BK4022","BK4232","LABU","BK4585","BK4139","BK4588","R"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659907385","title":"Sector Update: Healthcare Stocks Advance Late Afternoon","url":"https://stock-news.laohu8.com/highlight/detail?id=2659907385","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659907385?lang=en_us&edition=fundamental","pubTime":"2026-08-13 03:58","pubTimestamp":1786564721,"startTime":"0","endTime":"0","summary":"Healthcare stocks were higher late Wednesday afternoon, with the NYSE Healthcare Index up 0.2% and the State Street Health Care Select Sector SPDR ETF  adding 0.3%.The iShares Biotechnology ETF  rose 0.5%.In corporate news, Merck  shares rose 2.4% after Daiwa upgraded the stock to outperform from neutral and raised its price target to $143 per share from $120.Cencora  said that certain Walgreens volume that was being serviced by the company, separate from the prime vendor agreement, has started moving outside the company from July 1. Meanwhile, Cencora said its prime vendor agreement remains unchanged and accounts for the majority of its business with Walgreens. Cencora shares fell past 5%.Legend Biotech  could see pressures from competition and recent leadership change, potentially weighing on Carvykti myeloma therapy strategy, Oppenheimer said. It downgraded Legend to perform from outperform. Shares fell 5.2%.Definium Therapeutics  shares rose 5% after the firm said its phase 3 trial","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["MEMS","LU1093756168.USD","BK4139","LU1934455194.USD","SG9999004303.SGD","IE00BLSP4452.SGD","SG9999002224.SGD","IE00B4R5TH58.HKD","LU1037948541.HKD","BK4175","LU2089984988.USD","LU0006306889.USD","SG9999001440.SGD","LU0130102774.USD","LU1093756325.SGD","LU1057294990.SGD","DFTX","FHLC","LU0861579265.USD","LU2125909247.SGD","LU0965508806.USD","LU1116320737.USD","LABU","LU2361044865.SGD","SG9999014559.SGD","IE00BJT1NW94.SGD","LU1261432733.SGD","LU2023250843.SGD","LU1974910355.USD","LU0942090050.USD","LU0965509010.AUD","LU2491050071.SGD","LU0266013472.USD","BK4581","LU0203347892.USD","LU0211331839.USD","LU0648001328.SGD","LU2360032135.SGD","LU0106261372.USD","LU1929549753.HKD","IE0002141913.USD","BK4516","LU0265550946.USD","LU1035773651.USD","BK4588","SG9999014567.USD","LU1941712264.USD","LU0477156953.USD","LU1585245621.USD","LU1061106388.HKD","BK4533","GDOC","TRUH","BK4550","PPH","IE00BJJMRZ35.SGD","LU0238689110.USD","IE000M9KFDE8.USD","IE00BLSP4239.USD","IE00B1BXHZ80.USD","LU1066053197.SGD","LU1989771016.USD","LU1119994496.HKD","LU2468319806.SGD","LU1917777945.USD","LU1066051498.USD","LU1162221912.USD","LU0868494708.USD","SG9999013999.USD","LU1989772923.USD","LU2361044949.HKD","PAWZ","LU0859254822.USD","IE00B2B36J28.USD","BK4534","SG9999002232.USD","LU2106854487.HKD","LU1989772840.SGD","BK4585","BMED","LU2461242641.AUD","IHE","LU0208291251.USD","CANC","LU0234572021.USD","LU0122379950.USD","SGXZ23171101.USD","LU2125909593.SGD","LU1201861249.SGD","IE0009355771.USD","LU1023059063.AUD","LU2361045086.USD","LU1934455277.USD","LU0098860793.USD","RXL","IE00BSNM7G36.USD","LU0320765646.SGD","XLV","SG9999014575.USD","LEGN","LU1069347547.HKD","LU2112291526.USD","LU2491049909.HKD","LU1571399168.USD","LU0289739699.SGD","IXJ","LU2237957902.USD","LU1941712348.USD","BK4084","LU0965509283.SGD","XBI","LU0868494617.USD","LU0265550359.USD","LU0985320562.USD","JDOC","FTXH","LU1037948897.HKD","HRTS","LU1430594728.SGD","SG9999015341.SGD","LU0124676726.USD","BK4007","LU0058720904.USD","LU0070302665.USD","LU0130517989.USD","LU1923622614.USD","LU0965509101.SGD","LU2125154935.USD","LU2237957811.SGD","SG9999015358.SGD","IE00BFTCPJ56.SGD","SGXZ57979304.SGD","COR","LU1291159041.SGD","LU2491050154.USD","BK4529","SG9999001176.USD","LU1934455863.HKD","LU0203345920.USD","LU2324357040.USD","LU2023250504.SGD","LU1699723380.USD","BK4505","LU1983299246.USD","LU1116320901.HKD","LU1814569148.SGD","IE00BBT3K403.USD","LU2433249047.HKD","LU1084165304.USD","LU2125154778.USD","MEDI","LU0689626769.HKD","SG9999001176.SGD","LU0320765489.SGD","VHT","LU1066051225.USD","BK4559","IYH","IBB","LU1066051811.HKD","LU2357627491.SGD","MRK","IE00BN8TJ469.HKD","LU0823416689.USD","SG9999014542.SGD","LU0432979614.USD","LU0980610538.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659807180","title":"NeuroScientific locks in key US FDA meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2659807180","media":"The West Australian","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659807180?lang=en_us&edition=fundamental","pubTime":"2026-08-13 03:16","pubTimestamp":1786562166,"startTime":"0","endTime":"0","summary":"NeuroScientific Biopharmaceuticals has secured a key Pre-IND meeting with the US FDA on Aug 31 for its planned Phase 2 trial of its StemSmart technology, targeting refractory Crohn’s disease in the US.","market":"us","thumbnail":"https://images.thewest.com.au/publication/C-22718711/19d1a1436c2776b2838ed9f86b8617d1bb773169.jpg","type":0,"news_type":0,"thumbnails":["https://images.thewest.com.au/publication/C-22718711/19d1a1436c2776b2838ed9f86b8617d1bb773169.jpg"],"rights":{"source":"thewest_stock","url":"https://thewest.com.au/business/bulls-n-bears/neuroscientific-locks-in-key-us-fda-meeting-c-22718711","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://thewest.com.au/business/bulls-n-bears/neuroscientific-locks-in-key-us-fda-meeting-c-22718711","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"thewest_stock","symbols":["BK4528","SAP","BK4613","BK4023","BK4585","BK4588","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659041419","title":"HC Wainwright Starts Theriva (TOVX) at Buy on Undervalued Oncolytic Virus Platform and Advancing VCN-01 Pancreatic Cancer Program","url":"https://stock-news.laohu8.com/highlight/detail?id=2659041419","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659041419?lang=en_us&edition=fundamental","pubTime":"2026-08-13 01:55","pubTimestamp":1786557343,"startTime":"0","endTime":"0","summary":"Theriva Biologics, the Healthcare sector company, was revisited by a Wall Street analyst yesterday. Analyst Jason McCarthy from Maxim Group maintai...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/hc-wainwright-starts-theriva-tovx-at-buy-on-undervalued-oncolytic-virus-platform-and-advancing-vcn-01-pancreatic-cancer-program-ratings-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/hc-wainwright-starts-theriva-tovx-at-buy-on-undervalued-oncolytic-virus-platform-and-advancing-vcn-01-pancreatic-cancer-program-ratings-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["XLV","TOVX","LABU","BK4588","BK4585","XBI","BK4139","BK4581"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659356904","title":"Acadia Healthcare (ACHC) Securities Lawsuit Moves Forward After Court Denies Dismissal Bid","url":"https://stock-news.laohu8.com/highlight/detail?id=2659356904","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659356904?lang=en_us&edition=fundamental","pubTime":"2026-08-13 01:30","pubTimestamp":1786555844,"startTime":"0","endTime":"0","summary":"Acadia Healthcare Company, Inc. (ACHC) will continue facing a federal securities lawsuit after a Tennessee federal judge denied the defendants’ mot...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/class-action/acadia-healthcare-achc-securities-lawsuit-moves-forward-after-court-denies-dismissal-bid?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/class-action/acadia-healthcare-achc-securities-lawsuit-moves-forward-after-court-denies-dismissal-bid?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4581","BK4585","ACHC","XLV","BK4185","XBI","BK4588","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659901648","title":"Analysts Offer Insights on Healthcare Companies: NextCure (NXTC) and CalciMedica (CALC)","url":"https://stock-news.laohu8.com/highlight/detail?id=2659901648","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659901648?lang=en_us&edition=fundamental","pubTime":"2026-08-13 01:00","pubTimestamp":1786554032,"startTime":"0","endTime":"0","summary":"Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on NextCure (NXTC) and CalciMedica (CALC). NextCure (...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-nextcure-nxtc-and-calcimedica-calc-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-nextcure-nxtc-and-calcimedica-calc-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LABU","CALC","BK4581","XLV","BK4137","BK4585","LU0029874061.USD","BK4139","HCSG","BK4007","XBI","NXTC","LU0128526141.USD","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659901615","title":"Analysts Offer Insights on Healthcare Companies: BioNano Genomics (BNGO), Liquidia Technologies (LQDA) and PolyPid (PYPD)","url":"https://stock-news.laohu8.com/highlight/detail?id=2659901615","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659901615?lang=en_us&edition=fundamental","pubTime":"2026-08-13 00:50","pubTimestamp":1786553410,"startTime":"0","endTime":"0","summary":"Analysts have been eager to weigh in on the Healthcare sector with new ratings on BioNano Genomics (BNGO), Liquidia Technologies (LQDA) and PolyPid...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-bionano-genomics-bngo-liquidia-technologies-lqda-and-polypid-pypd-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-bionano-genomics-bngo-liquidia-technologies-lqda-and-polypid-pypd-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4575","XBI","BK4121","BK4588","LABU","LU0029874061.USD","LU0128526141.USD","BK4007","XLV","BK4137","BK4581","BNGO","BK4585","PYPD","LQDA","HCSG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658086839","title":"Freenome Says It Has Obtained FDA Breakthrough Device Designation for Lung Cancer Screening Test","url":"https://stock-news.laohu8.com/highlight/detail?id=2658086839","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658086839?lang=en_us&edition=fundamental","pubTime":"2026-08-12 21:29","pubTimestamp":1786541387,"startTime":"0","endTime":"0","summary":"Freenome  has obtained breakthrough device designation for its investigational lung cancer screening test SimpleScreen Lung from the US Food and Drug Administration, the company said Wednesday.The designation applies to the proposed use of SimpleScreen Lung in adults aged 50 to 80 years who have at least a 20 pack-year smoking history and are currently participating in guideline-recommended lung cancer screening, according to a statement.Freenome said that the clinical evaluation of the test is ongoing.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4585","FRNM","LABU","BK4139","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658961908","title":"FDA Grants Breakthrough Device Designation to Freenome’s Blood-Based SimpleScreen™ Lung Cancer Screening Test","url":"https://stock-news.laohu8.com/highlight/detail?id=2658961908","media":"GlobeNewswire","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658961908?lang=en_us&edition=fundamental","pubTime":"2026-08-12 21:00","pubTimestamp":1786539600,"startTime":"0","endTime":"0","summary":"Investigational AI-powered multiomic test is being developed for adults ages 50-80 at high risk who are not currently participating in guideline-recommended lung cancer screeningBRISBANE, Calif., Aug.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/08/12/3343694/0/en/fda-grants-breakthrough-device-designation-to-freenome-s-blood-based-simplescreen-lung-cancer-screening-test.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","BK4585","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658709499","title":"Analysts Offer Insights on Healthcare Companies: Genmab (GMAB), Definitive Healthcare Corp (DH) and Atai Beckley N.V. (ATAI)","url":"https://stock-news.laohu8.com/highlight/detail?id=2658709499","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658709499?lang=en_us&edition=fundamental","pubTime":"2026-08-12 20:50","pubTimestamp":1786539013,"startTime":"0","endTime":"0","summary":"Analysts have been eager to weigh in on the Healthcare sector with new ratings on Genmab (GMAB), Definitive Healthcare Corp (DH) and Atai Beckley N...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-genmab-gmab-definitive-healthcare-corp-dh-and-atai-beckley-n-v-atai-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-genmab-gmab-definitive-healthcare-corp-dh-and-atai-beckley-n-v-atai-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4585","BK4539","GMAB","BK4139","XBI","BK4581","ATAI","BK4007","BK4588","LABU","XLV","BK4167","DH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658970958","title":"Analysts’ Opinions Are Mixed on These Healthcare Stocks: AIM ImmunoTech (AIM) and Schrodinger (SDGR)","url":"https://stock-news.laohu8.com/highlight/detail?id=2658970958","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658970958?lang=en_us&edition=fundamental","pubTime":"2026-08-12 20:40","pubTimestamp":1786538419,"startTime":"0","endTime":"0","summary":"Analysts have been eager to weigh in on the Healthcare sector with new ratings on AIM ImmunoTech (AIM) and Schrodinger (SDGR). AIM ImmunoTech (AIM)...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-opinions-are-mixed-on-these-healthcare-stocks-aim-immunotech-aim-and-schrodinger-sdgr-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-opinions-are-mixed-on-these-healthcare-stocks-aim-immunotech-aim-and-schrodinger-sdgr-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4588","BK4139","XBI","LABU","BK4137","AIM","BK4167","BK4581","HCSG","LU0128526141.USD","SDGR","XLV","LU0029874061.USD","BK4557","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658997785","title":"Analysts Offer Insights on Healthcare Companies: 908 Devices (MASS), Pediatrix Medical Group (MD) and BridgeBio Oncology Therapeutics (BBOT)","url":"https://stock-news.laohu8.com/highlight/detail?id=2658997785","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658997785?lang=en_us&edition=fundamental","pubTime":"2026-08-12 20:20","pubTimestamp":1786537240,"startTime":"0","endTime":"0","summary":"Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on 908 Devices (MASS), Pediatrix Medical Group (MD) a...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-908-devices-mass-pediatrix-medical-group-md-and-bridgebio-oncology-therapeutics-bbot-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-908-devices-mass-pediatrix-medical-group-md-and-bridgebio-oncology-therapeutics-bbot-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["HCSG","MASS","XLV","BK4588","BK4585","BK4581","MD","BK4139","LABU","XBI","LU0128526141.USD","BBOT","LU0029874061.USD","BK4157","BK4196","BK4137"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658990864","title":"Autonomix Medical Completes Good Laboratory Practice (GLP) Preclinical Study, Marking Key Step Toward FDA Submission","url":"https://stock-news.laohu8.com/highlight/detail?id=2658990864","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658990864?lang=en_us&edition=fundamental","pubTime":"2026-08-12 20:15","pubTimestamp":1786536900,"startTime":"0","endTime":"0","summary":"Final histology and laboratory analyses support the study’s safety and performance objectives THE WOODLANDS, TX, Aug.  12, 2026 (GLOBE NEWSWIRE) -- Autonomix Medical, Inc.(NASDAQ: AMIX) (“Autonomix” o","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/08/12/3343626/0/en/autonomix-medical-completes-good-laboratory-practice-glp-preclinical-study-marking-key-step-toward-fda-submission.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LABU","BK4585","BK4082","GLP","AMIX","BK4588","BK4590","BK4144"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658974286","title":"Analysts Offer Insights on Healthcare Companies: Travere Therapeutics (TVTX), Maze Therapeutics, Inc. (MAZE) and Immunome (IMNM)","url":"https://stock-news.laohu8.com/highlight/detail?id=2658974286","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658974286?lang=en_us&edition=fundamental","pubTime":"2026-08-12 19:40","pubTimestamp":1786534824,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Travere Therapeutics (TVTX), Maze Therapeutics, Inc....","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-travere-therapeutics-tvtx-maze-therapeutics-inc-maze-and-immunome-imnm-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-travere-therapeutics-tvtx-maze-therapeutics-inc-maze-and-immunome-imnm-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4585","HCSG","BK4588","BK4139","BK4007","LFSC","XLV","MAZE","TVTX","BK4563","XBI","FFTY","BK4581","LU0029874061.USD","IMNM","LU0128526141.USD","BK4137","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658974237","title":"TransMedics Buy Rating Reaffirmed as Analyst Maintains $95 Price Target on Robust Multi-Year Growth Outlook","url":"https://stock-news.laohu8.com/highlight/detail?id=2658974237","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658974237?lang=en_us&edition=fundamental","pubTime":"2026-08-12 19:35","pubTimestamp":1786534533,"startTime":"0","endTime":"0","summary":"TransMedics Group, the Healthcare sector company, was revisited by a Wall Street analyst yesterday. Analyst William Plovanic from Canaccord Genuity...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/transmedics-buy-rating-reaffirmed-as-analyst-maintains-95-price-target-on-robust-multi-year-growth-outlook-ratings-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/transmedics-buy-rating-reaffirmed-as-analyst-maintains-95-price-target-on-robust-multi-year-growth-outlook-ratings-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4588","LABU","BK4581","XLV","XBI","BK4585"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":20,"pageCount":16,"totalSize":398,"code":"91000000","status":"200"}]}}